What's new

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 March 2025

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 March 2025

Mar 14, 2025 - 14:43
 0
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 March 2025
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 March 2025
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Yesafili, aflibercept,...

Next Article

EPA to end environmental justice programs, monitoring tools

Related Posts

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Adtralza, Tralokinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0012/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 14, 2025  0

Human medicines European public assessment report (EPAR): Trydonis, beclometasone,formoterol,glycopyrronium bromide, Date of authorisation: 26/04/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0